Author

A. Bancod

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

B. La Scola· 2 shared C. Boschi· 2 shared P. Colson· 2 shared D. E. Scheim· 1 shared J. Fantini· 1 shared M. Le Bideau· 1 shared M. Millitello· 1 shared V. Moal· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

8 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

B. La Scola

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

SARS-CoV-2 Spike Protein Induces Hemagglutination: Implications for COVID-19 Morbidities and Therapeutics and for Vaccine Adverse Effects

C. Boschi, D. E. Scheim, A. Bancod, M. Millitello, M. Le Bideau, P. Colson, J. Fantini, B. La Scola

This study shows SARS-CoV-2 spike proteins from four lineages induce hemagglutination, with Omicron requiring lower concentrations, and ivermectin inhibits this effect, suggesting therapeutic and safety implications.

bioRxiv · Nov 24, 2022 · PreprintBiochemistry

Omicron variant escapes therapeutic mAbs contrary to eight prior main VOC

C. Boschi, P. Colson, A. Bancod, V. Moal, B. La Scola

The paper shows that the Omicron variant escapes neutralization by authorized mAbs, unlike previous variants, highlighting the need for updated protective measures for immunocompromised patients.

bioRxiv · Jan 3, 2022 · PreprintMicrobiology